Recro Pharma (REPH) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 53 254 sessions, March 19, 2021 to March 21, 2022
- Largest daily move
- +16.3% close of May 7, 2021
- 1-year change
- -41.5% closing prices, March 19, 2021 to March 21, 2022
- 1-month change
- +30.6% closing prices, February 18, 2022 to March 21, 2022
Company Description
Recro Pharma (Nasdaq: REPH) is classified in the drug manufacturers—specialty & generic industry within the Healthcare sector and carries a market capitalization of $123.2M.
REPH has declined 41.5% over the past year. The last closing price was $2.09.
This page collects what Stock Titan holds for REPH, including price data and latest news.
Stock Performance
Recro Pharma (REPH) closed at $2.09 on March 21, 2022. Over the past 12 months, the price has lost 41.5%.
REPH Metrics & Rankings
Price returns through March 21, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Recro Pharma has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences, clinical trial, management. View all REPH news →
SEC Filings
REPH Company Profile & Sector Positioning
Recro Pharma (REPH) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector.
Investors comparing REPH often look at related companies in the same sector, including GNTW (GNTW), Harborside, Inc. (HBORF), Gage Growth (GAEGF), Mallinckrodt Plc (MNKPF), and Lifecore Biomedical Inc. (LNDC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate REPH's relative position within its industry.